HCA Healthcare Reports Third Quarter 2020 Results

Go back to  HCA Healthcare Reports Third Quarter 2020 Results

HCA Holdings (HCA) PT Raised to $150 at Raymond James

October 26, 2020 4:48 PM EDT

Raymond James analyst John Ransom raised the price target on HCA Holdings (NYSE: HCA) to $150.00 (from $140.00) while maintaining a Outperform rating.

... More

HCA Holdings (HCA) Reports Q3 EPS of $1.95

October 26, 2020 7:33 AM EDT

HCA Holdings (NYSE: HCA) reported Q3 EPS of $1.95, may not compare to the analyst estimate of $2.32. Revenue for the quarter came in at $13.31 billion versus the consensus estimate of $12.87 billion.

For earnings history and earnings-related data on HCA Holdings (HCA) click here.

... More

HCA Holdings (HCA) Misses Q3 EPS by 37c, Revenues Beat

October 26, 2020 7:32 AM EDT

HCA Holdings (NYSE: HCA) reported Q3 EPS of $1.95, $0.37 worse than the analyst estimate of $2.32. Revenue for the quarter came in at $13.31 billion versus the consensus estimate of $12.87 billion.

Key third quarter metrics (all percentage changes compare 3Q 2020 to 3Q 2019 unless otherwise noted):

Revenues totaled $13.311 billionNet income attributable to HCA Healthcare, Inc. totaled $668 million, or $1.95 per diluted shareAdjusted EBITDA totaled $2.053 billionResults include reversal of $822 million, or $1.72 per diluted share, in government stimulus income from CARES Act fundsCash flows from operating activities totaled $2.717 billionSame facility admissions... More